tibsovo - ivosidenib tablet, film coated
(Ivosidenib)Servier Pharmaceutical Llc
Usage: Tibsovo is an IDH1 inhibitor for adults with susceptible IDH1 mutations. Indicated for newly diagnosed AML in patients 75+ or unfit for intensive chemotherapy, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes, and previously treated locally advanced or metastatic cholangiocarcinoma.